R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Director – Global Marketing

Product MarketingConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 10 years of progressive commercial experience in biotechnology and/or pharmaceuticals, including global strategic marketing or global brand responsibilities.
  • A demonstrated track record of developing and executing global brand strategies and translating insights into executable plans and deliverables.
  • Launch experience at a global, regional, or major-market level, with responsibility for core brand strategy, messaging, and enabling assets.
  • Strong understanding of the oncology ecosystem, including patients, caregivers, healthcare professionals, institutions, payers, and diagnostics stakeholders, and ability to learn complex disease areas, treatment pathways, and competitive landscapes.
  • Ability to lead cross-functional teams in a matrix environment and influence across an organization at all levels without direct authority.
  • Ability to operate effectively in a smaller, rapidly growing company.
  • Ability to derive insights and analytics that lead to innovative market strategies.
  • Ability to represent Revolution Medicines externally with professionalism and credibility.

Responsibilities

  • Develop critical aspects of global brand strategy and multi-year commercial plans, integrating customer, patient, and market insights into actionable strategic choices.
  • Serve as a thought partner to Global Commercial Development leadership, influencing portfolio strategy, lifecycle planning, investment prioritization, and commercialization decisions.
  • Shape global positioning, value proposition, and messaging architecture, and build and maintain the global promotional platform for consistent, compliant communications across markets.
  • Partner to inform insight-generation plans across disease state, customer segments, and treatment paradigms, including primary market research, competitive intelligence, and patient journey mapping.
  • Partner with Global Medical Affairs to translate clinical data into accurate, compliant scientific narratives and provide commercialization input on evidence generation, publication planning, and congress strategy.
  • Partner with Global Market Access colleagues to incorporate pricing, reimbursement, and access considerations into brand strategy and guide payer value messaging and value evidence plans, including HEOR and RWE.
  • Lead critical components of global launch readiness as a commercial workstream leader, driving cross-functional alignment and execution across global, regional, and local teams.
  • Develop and adapt global core assets and tools, including brand story, core claims and substantiation, visual identity guidance, unbranded disease education, HCP and patient education frameworks, and digital content standards, enabling localization by areas and affiliates.
  • Support testing and patient identification strategies for biomarker-driven oncology, as needed, including establishing and augmenting testing pathways and stakeholder education.
  • Manage agency-of-record and vendor relationships and workflows; develop scopes of work, set performance expectations, and ensure high-quality, timely deliverables.
  • Own key components of the global marketing budget for assigned programs; track spend, forecast, and ensure delivery within budget and company policies.
  • Define success metrics, including awareness, adoption drivers, HCP behavior change, and digital performance where applicable, and partner with Global Analytics and Insights to build dashboards and incorporate learnings into plan updates.
  • Travel as needed, typically up to 25–30%.

Desired Qualifications

  • An advanced degree such as an MBA, PhD, PharmD, or equivalent is preferred.
  • Local or affiliate marketing experience is a plus.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs